Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (271-280 of 363) with videos related to

Pageof 37
Sort By:
AIDS (London, England)|December 28, 2000
Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infectionG R Kaufmann, J J Zaunders, P Cunningham, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modelingG R Kaufmann, J Zaunders, J Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populationsS C Meuer, D A Cooper, J C Hodgdon, et al.
HIV Medicine|February 12, 2009
Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapyH Byakwaga, J Zhou, K Petoumenos, et al.
Science (New York, N.Y.)|December 16, 1983
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytesS C Meuer, D A Cooper, J C Hodgdon, et al.
HIV Medicine|March 19, 2010
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trialA Calmy, M Bloch, H Wand, et al.
HIV Medicine|November 27, 2018
Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation StudyR Puhr, K Petoumenos, R Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?P Vanhems, R Allard, D A Cooper, et al.
AIDS (London, England)|June 15, 2000
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolatesP Vanhems, R Gaudet, B Hirschel, et al.
AIDS (London, England)|October 2, 2001
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre studyA Carr, J Hudson, J Chuah, et al.
Pageof 37

Showing results (271-280 of 363) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|December 28, 2000
Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infectionG R Kaufmann, J J Zaunders, P Cunningham, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modelingG R Kaufmann, J Zaunders, J Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populationsS C Meuer, D A Cooper, J C Hodgdon, et al.
HIV Medicine|February 12, 2009
Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapyH Byakwaga, J Zhou, K Petoumenos, et al.
Science (New York, N.Y.)|December 16, 1983
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytesS C Meuer, D A Cooper, J C Hodgdon, et al.
HIV Medicine|March 19, 2010
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trialA Calmy, M Bloch, H Wand, et al.
HIV Medicine|November 27, 2018
Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation StudyR Puhr, K Petoumenos, R Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?P Vanhems, R Allard, D A Cooper, et al.
AIDS (London, England)|June 15, 2000
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolatesP Vanhems, R Gaudet, B Hirschel, et al.
AIDS (London, England)|October 2, 2001
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre studyA Carr, J Hudson, J Chuah, et al.
Pageof 37